• Policy
• Antengene starts Xpovio's reimb pricing negotiations in KOR
• by Lee, Tak-Sun May 29, 2024 05:45am

• Policy
• Only 15 of the 61 Trajenta generics will be released in KOR
• by Lee, Tak-Sun May 29, 2024 05:45am

• Company
• Multinational pharmaceutical companies post mixed results
• by Son, Hyung-Min May 28, 2024 01:31pm

• Company
• Handok strengthens global pharma partnerships
• by Kim, Jin-Gu May 28, 2024 05:52am

• Company
• Roche’s Kadcyla sales KRW 70 bil…unrivaled lead in ADC mkt
• by Nho, Byung Chul May 28, 2024 05:52am

• Company
• ‘Amgen’s success is based on its people and culture’
• by Eo, Yun-Ho May 28, 2024 05:52am

• Company
• Global pharmaceutical companies acquire radiopharmaceuticals
• by Son, Hyung-Min May 28, 2024 05:52am

• Opinion
• [Reporter’s View] Lung cancer but also a 'rare disease'
• by Eo, Yun-Ho May 27, 2024 05:48am

• Policy
• New dementia drug Leqembi receives approval
• by Lee, Hye-Kyung May 27, 2024 05:48am

• Policy
• Tepmetko reapplies for reimb in Korea for the third time
• by Lee, Tak-Sun May 27, 2024 05:48am